Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Are Tumor Cell Lineages Solely Shaped by Mechanical Forces?

Leroy-Lerêtre M, Dimarco G, Cazales M, Boizeau ML, Ducommun B, Lobjois V, Degond P.

Bull Math Biol. 2017 Oct;79(10):2356-2393. doi: 10.1007/s11538-017-0333-y. Epub 2017 Aug 29.

2.

Imaging tissue-mimic with light sheet microscopy: A comparative guideline.

Andilla J, Jorand R, Olarte OE, Dufour AC, Cazales M, Montagner YL, Ceolato R, Riviere N, Olivo-Marin JC, Loza-Alvarez P, Lorenzo C.

Sci Rep. 2017 Mar 21;7:44939. doi: 10.1038/srep44939.

3.

Cell-Cell Adhesion and Cytoskeleton Tension Oppose Each Other in Regulating Tumor Cell Aggregation.

Saias L, Gomes A, Cazales M, Ducommun B, Lobjois V.

Cancer Res. 2015 Jun 15;75(12):2426-33. doi: 10.1158/0008-5472.CAN-14-3534. Epub 2015 Apr 8.

4.

Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D.

Laurent J, Frongia C, Cazales M, Mondesert O, Ducommun B, Lobjois V.

BMC Cancer. 2013 Feb 8;13:73. doi: 10.1186/1471-2407-13-73.

5.

Identification of N-terminally truncated stable nuclear isoforms of CDC25B that are specifically involved in G2/M checkpoint recovery.

Jullien D, Bugler B, Dozier C, Cazales M, Ducommun B.

Cancer Res. 2011 Mar 1;71(5):1968-77. doi: 10.1158/0008-5472.CAN-10-2453.

6.

A screen for deubiquitinating enzymes involved in the G₂/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stability.

Aressy B, Jullien D, Cazales M, Marcellin M, Bugler B, Burlet-Schiltz O, Ducommun B.

Cell Cycle. 2010 Sep 15;9(18):3815-22. doi: 10.4161/cc.9.18.13133. Epub 2010 Sep 25.

PMID:
20930503
7.

Decreased motivational properties of morphine in mouse models of cancerous- or inflammatory-chronic pain: implication of supraspinal neuropeptide FF(2) receptors.

Betourne A, Familiades J, Lacassagne L, Halley H, Cazales M, Ducommun B, Lassalle JM, Zajac JM, Frances B.

Neuroscience. 2008 Nov 11;157(1):12-21. doi: 10.1016/j.neuroscience.2008.08.045. Epub 2008 Aug 29.

PMID:
18804517
8.

A new mitotic-cell specific monoclonal antibody.

Cazales M, Quaranta M, Lobjois V, Jullien D, Al Saati T, Delsol G, Ducommun B.

Cell Cycle. 2008 Jan 15;7(2):267-8. Epub 2007 Nov 7. No abstract available.

PMID:
18256524
9.

Pharmacologic inhibition of CDC25 phosphatases impairs interphase microtubule dynamics and mitotic spindle assembly.

Cazales M, Boutros R, Brezak MC, Chaumeron S, Prevost G, Ducommun B.

Mol Cancer Ther. 2007 Jan;6(1):318-25.

10.

CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage.

Cazales M, Schmitt E, Montembault E, Dozier C, Prigent C, Ducommun B.

Cell Cycle. 2005 Sep;4(9):1233-8. Epub 2005 Sep 23.

PMID:
16082213
11.

Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition.

Dutertre S, Cazales M, Quaranta M, Froment C, Trabut V, Dozier C, Mirey G, Bouché JP, Theis-Febvre N, Schmitt E, Monsarrat B, Prigent C, Ducommun B.

J Cell Sci. 2004 May 15;117(Pt 12):2523-31. Epub 2004 May 5.

12.

A novel synthetic inhibitor of CDC25 phosphatases: BN82002.

Brezak MC, Quaranta M, Mondésert O, Galcera MO, Lavergne O, Alby F, Cazales M, Baldin V, Thurieau C, Harnett J, Lanco C, Kasprzyk PG, Prevost GP, Ducommun B.

Cancer Res. 2004 May 1;64(9):3320-5.

13.

PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation.

Baldin V, Theis-Febvre N, Benne C, Froment C, Cazales M, Burlet-Schiltz O, Ducommun B.

Biol Cell. 2003 Nov;95(8):547-54.

PMID:
14630392
14.

Protein kinase CK2 regulates CDC25B phosphatase activity.

Theis-Febvre N, Filhol O, Froment C, Cazales M, Cochet C, Monsarrat B, Ducommun B, Baldin V.

Oncogene. 2003 Jan 16;22(2):220-32.

PMID:
12527891
15.

Nuclear localization of CDC25B1 and serine 146 integrity are required for induction of mitosis.

Baldin V, Pelpel K, Cazales M, Cans C, Ducommun B.

J Biol Chem. 2002 Sep 20;277(38):35176-82. Epub 2002 Jul 9.

Supplemental Content

Loading ...
Support Center